Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
NEW YORK - SELLAS Life Sciences Group, Inc. (NASDAQ: NASDAQ:), a biopharmaceutical firm specializing in most cancers therapies, introduced right now that its...
Exploring the way forward for veterinary oncology, Neal Mauldin, DVM, ACVIM, ACVR, Thrive Pet Healthcare’s nationwide director of radiation oncology and chief medical...
